OLT1177, a β-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation

Carlo Marchetti(University of Colorado Denver), Charles A. Dinarello(University of Colorado Health), Curtis J. Henry(Emory University), Sonia Carta(Ospedale Policlinico San Martino), C. Preston Neff(Ospedale Policlinico San Martino), Damaris B. Skouras(Olatec (United States)), Roy D. Altman, Veronika Grau(University of Giessen), Tania Azam(Ospedale Policlinico San Martino), Leo A. B. Joosten(Radboud University Nijmegen), Katrin Richter(Justus-Liebig-Universität Gießen), Curtis L. Scribner(Olatec (United States)), Travis Nemkov(Touch of Life Technologies (United States)), Angelo D’Alessandro(University of Colorado Anschutz Medical Campus), Robert B. Barrow(Olatec (United States)), Benjamin J. Swartzwelter(Ospedale Policlinico San Martino), Isak W. Tengesdal(Radboud University Nijmegen), Marco Gattorno(Istituto Giannina Gaslini), Joseph P. St. Laurent(EIC Laboratories), Scott A. Goodrich(EIC Laboratories), Anna Rubartelli(National Cancer Research Institute), Gerald S. Jones(EIC Laboratories), Sabina Janciauskiene(Medizinische Hochschule Hannover), Terry M. Jones(J&S Studies), Fabia Gamboni(Ospedale Policlinico San Martino)
Proceedings of the National Academy of Sciences
January 29, 2018
Cited by 556


Related Papers